baber/WOPTO huggingface dataset:
Patent NZ-504093-A (NZ)
Title: Paper furnish comprising aluminium and modified starch cooked with a polyacrylamide
Inventor: MOFFETT ROBERT HARVEY
IPC: D21H17/65
Filed: 1998-10-23
Abstract: The paper furnish contains: (a) a soluble aluminium compound selected from the group consisting of aluminium sulfate, aluminates, aluminium nitrate, polyaluminium chloride and polyaluminium sulfate, present in the amount of approximately 0.005 to 2.5 kilograms of Al2O3 per metric ton of dry paper, and (b) a modified starch prepared by cooking an aqueous solution of at least one amphoteric or cationic starch having a degree of substitution between about 0.01 to 0.2 with at least one nonionic or amphoteric polyacrylamide, or cationic or anionic polyacrylamide having a degree of substitution between 1% and 80% by weight, having a molecular weight of at least 500,000, with the provisos that:  (i) cooking is conducted at a pH above 7.0 in the case that a cationic or non-ionic polyacrylamide is selected; (ii) cooking produces no more than 75% neutralization of the cationic starch if the anionic polyacrylamide molecular weight is [1,000,000 and no more than 50% neutralization of the cationic starch if the anionic polyacrylamide molecular weight is  ³8,000,000; and (iii) the weight ratio of starch to polyacrylamide is greater than 2 to 1.
Patent NZ-507174-A (NZ)
Title: Stimulus sensitive polymer gel with radioisotape and methods of making
Inventor: LIND MICHAEL A
IPC: A61K9/10
Filed: 1999-04-06
Abstract: A thermally reversible stimulus-sensitive gel or gelling copolymer radioisotope carrier that is a linear random copolymer of an [meth-]acrylamide derivative and a hydrophilic comonomer, wherein the linear random copolymer is in the form of a plurality of linear chains having a plurality of molecular weights greater than or equal to a minimum gelling molecular weight cutoff is disclosed. The method of making a thermally reversible stimulus- sensitive gelling copolymer radionuclcide carrier has the steps of: (a) mixing a stimulus-sensitive reversible gelling copolymer with an aqueous solvent as a stimulus-sensitive reversible gelling solution; and (b) mixing a radioisotope with said stimulus-sensitive reversible gelling solution as said radioisotope carrier. Addition of a biodegradable backbone and/or a therapeutic agent imparts further utility. The gel is enhanced by either combining it with a biodegradable backbone and/or a therapeutic agent in a gelling solution made by mixing the copolymer with an aqueous solvent.
Patent NZ-507745-A (NZ)
Title: Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine
Inventor: CURRIE ROBIN
IPC: A61K31/7076
Filed: 1999-04-26
Abstract: A pharmaceutical composition comprising: i) abacavir; ii) lamivudine; iii) zidovudine; and iv) a pharmaceutically acceptable glidant which is magnesium stearate. The amount of abacavir, lamivudine and zidovudine are in an amount of 30% to 70% of total composition weight. Magnesium stearate is in an amount of 0.05% to 5.0% of total composition weight.
Patent NZ-508062-A (NZ)
Title: Enumeration method of analyte detection
Inventor: STARZL TIMOTHY W
IPC: G01N33/543
Filed: 1999-05-13
Abstract: This system is directed to an optically-based method and system for analyte detection using solid phase immobilization, specific analyte labels adapted for signal generation and corresponding processes for the utilization thereof. The enumeration detection method disclosed herein narrows the area for signal observation, thus, improving detectable signal to background ratio. The system is comprised of a platform/support for immobilizing a sample stage having a labeled sample (analyte complex) bound thereto, a radiation source, an optical apparatus for generating and directing radiation at said sample and a means for data collection and analysis. Upon engagement of the system, the sample generates a signal capable of differentiation from background signal, both of which are collected and imaged with a signal detector that generated a sample image to a data processing apparatus. Said apparatus receives signal measurements and, in turn, enumerates individual binding events. Generated signal may be increased via selected mass enhancement. The invention, enumeration assay methodology detecting individual binding events, may be used, for example, in analyses to detect analyte or confirm results in both research, commercial and point of care applications.
Patent NZ-509114-A (NZ)
Title: Carrier for children, for securing in cars
Inventor: ANN-KRISTIN BJERKAN
IPC: B60N2/28
Filed: 2000-04-17
Abstract: Device for securing a carrier (1) for children, shaped as a box or basket, in a car with seat belts in the rear seat. At, or close to, an elongated side of the carrier (1), bands (2) are fastened. The bands (2) have fastening devices (4) that may be secured in reciprocal locking mechanisms (not shown) from the existing seat belts in a car. The carrier (1) preferably has a permanent set of harness (11) for securing the child, preferably a five-point harness.
Patent NZ-511687-A (NZ)
Title: Topical compositions comprising ascomycins
Inventor: KRIWET KATRIN
IPC: A61K31/445
Filed: 1999-12-01
Abstract: The present invention relates to a composition for topical administration comprising an ascomycin and a carrier vehicle comprising means to retain water in the outer skin layer and means to hinder water evaporating from the skin.
Patent NZ-512831-A (NZ)
Title: Process for producing an expanded foodstuff
Inventor: KEOGH ANDREW JOSEPH
IPC: A23L1/00
Filed: 2000-01-17
Abstract: A process for producing expanded foodstuffs  (i.e. contain air and/or other gases) whereby a soft expanded foodstuff composition at a first temperature and pressure is passed into a setting region at a second, lower temperature and pressure to cool and set.
Patent NZ-514709-A (NZ)
Title: Heterocyclic substituted 1,4-benzene dimethanamine derivatives useful for treating disorders mediated by chemokine receptor binding or associated with an abnormal immune response
Inventor: BRIDGER GARY
IPC: A61P17/00
Filed: 2000-03-24
Abstract: A     compound    of    Formula    I     Y-W(X)(Z)- (CR1R2)nArCR3R4N(R5)(CR6R7)nR8   or    a    pharmaceutically acceptable  acid  addition salt thereof or a  stereoisomeric form or a mixture thereof wherein: W is a nitrogen atom and Y is void or W is a carbon atom and Y is H; R1  to  R7  are independently hydrogen, cycloalkyl or  alkyl provided that when W is N R5 is no alkyl substituted with  a heteroaryl group; R is a substituted heterocyclic or aromatic group Ar  is  an optionally substituted aromatic or heteroaromatic ring; n and n' are independently 0 to 2; X is a group of the formula of formula (II) or (III); Ring A is an optionally substituted, optionally saturated  5 or 6 membered ring; Q is an optionally substituted carbon or nitrogen atom or is sulphur  or oxygen atom provided that A in formula (II)  and R8  cannot be unsubstituted 2=pyridyl when both Z and R5 are methyl and W is N; Ring B is an optionally substituted 5 to 7-membered ring;   Ring  A  or Ring B are bound to group W from any  position through group V; V is a chemical bond, C(=O) or (CH2)n"; n" is 0 to 2 and Z  is H, optionally substituted alkyl group or an C0-6 alkyl substituted  with  an  optionally  substituted  aromatic  or heterocyclic  group  or  Z  is  an  optionally   substituted alkylamino   or     cycloalkylamino  or  is  an   optionally substituted carbonyl group or sulphonyl. The  compounds  are  useful to treat disorders  mediated  by chemokine  receptor binding or associated with  an  abnormal immune response.
Patent NZ-521230-A (NZ)
Title: Truss brace with retainers at opposite ends and truss structure made therewith
Inventor: PELLOCK MICHAEL A
IPC: E04B7/02
Filed: 2001-02-28
Abstract: A brace for use in spacing structural trusses in a truss system is disclosed, wherein each truss being formed by truss components, the brace comprising a beam having opposite first and second ends, a first retainer extending from the first end of the beam, the first retainer having a transversely extending channel adapted to receive a truss component therein and to connect the brace to a truss in a self-retaining position on the truss such that the beam extends generally perpendicularly outwardly from the truss toward an adjacent truss in the truss system, said first retainer is constructed for resiliently flexing when receiving a truss component for snap-locking engagement with the truss component, a second retainer extending from the second end of the beam being adapted for engaging said adjacent truss for holding said adjacent truss and the truss in spaced relation relative to each other within the truss system. A truss system utilising braces to retain the trusses in spaced relation is shown. The braces include a beam with retainers at opposite ends for forming a snap lock connection to adjacent trusses, fixing the spacing between the trusses. One retainer includes a yoke that will automatically position the brace in an orientation generally normal to the truss to which the brace is mounted. The other retainer is adapted to mount to an adjacent truss and form an interlock with a second brace extending to the next truss. The braces are lined in a row across a plurality of trusses positioned in generally parallel relationship.
Patent NZ-522427-A (NZ)
Title: A therapeutic chemical agent of the macrocyclic diterpene family obtainable from a member of the Euphorbiaceae family of plants, use and preparation process thereof
Inventor: AYLWARD JAMES HARRISON
IPC: A61K48/00
Filed: 2001-06-07
Abstract: A therapeutic chemical agent useful in the treatment and prophylaxis of infection by pathogenic or potentially pathogenic entities, or entities capable of opportunistic infection in mammals, including humans and primates, non-mammalian animals and avian species is disclosed. This chemical agent of the macrocyclic diterpene family is obtained from a member of the Euphorbiaceae family of plants or botanical or horticultural relatives thereof or derivatives or chemical analogues or chemically synthetic forms of the agents for use in the treatment or prophylaxis of infection by pathogenic entities in mammalian, animal and avian subjects. A method for the prophylaxis and/or treatment in mammalian, animal or avian subjects of infection or potential infection by pathogenic entities by the topical or systemic administration of a macrocyclic diterpene obtainable from a member of the Euphorbiaceae family of plants or their botanical or horticultural derivatives or a derivative, chemical analogue or chemically synthetic form of the agent is also disclosed. This chemical agent may be in the form of a purified compound, mixture of compounds, a precursor form of one or more of the compounds capable of chemical transformation into a therapeutically active agent or in the form of a chemical fraction, sub-fraction, preparation or extract of the plant.
Patent NZ-523246-A (NZ)
Title: Composite excipient particles with a mass medium aerodynamic or a volume median diameter of less that 1 micron produced by milling
Inventor: STANIFORTH JOHN NICHOLAS
IPC: A61K31/58
Filed: 2001-06-27
Abstract: Described is a method for making composite excipient particles for use in a pharmaceutical composition comprising a milling step in which particles of an excipient material are milled in the presence of an additive material, wherein the milling step results in the additive material being applied to the surface of the excipient material. The product particles are of small size and the milling requires relatively low input of time and energy. The composite particles are suitable for use in inhalable pharmaceutical compositions.
Patent NZ-527384-A (NZ)
Title: Control system with capacitive sensor to provide a signal responsive to a rate of change in capacitance
Inventor: WADLOW DAVID
IPC: H03K17/955
Filed: 2002-01-30
Abstract: A capacitive sensor system for controlling operation of a device in response to a rate of change in capacitance due to motion of a proximate object includes at least two sense electrodes disposed on a surface and a phase locked loop, including a voltage controlled oscillator and a phase/frequency comparator, connected between the sense electrodes and an RC network for providing an operating frequency to the sense electrodes. A circuit loop, including a reference oscillator, provides a fixed frequency references for the phase locked loop to follow and a phase delay circuit connected between said phase/frequency comparator and said voltage controlled oscillator causes the voltage controlled oscillation to run ahead of the reference oscillator. A trigger circuit provides a control output in response to a change in phase shift frequency and said operating frequency.
Patent NZ-534881-A (NZ)
Title: Mammalian GnTIII expression in plants
Inventor: BAKKER HENDRIKUS ANTONIUS CORN
IPC: A61K38/00
Filed: 2003-03-18
Abstract: An isolated hybrid glycosyltransferase plant protein comprising an active site of GnTIII and a transmembrane region of a protein, where the protein resides in the endoplasmic reticulum or the Golgi apparatus of a cell. Also disclosed is the use and composition of the protein.
Patent NZ-537394-A (NZ)
Title: Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
Inventor: CYWIN CHARLES L
IPC: A61P25/00
Filed: 2003-06-03
Abstract: Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds of formula (I), wherein R1 and R2 are as defined in the specification, which are useful as inhibitors of the kinase activity of the IkappaB kinase (IKK) complex are disclosed. The compounds are therefore useful in the treatment of IKK mediated diseases including autoimmune diseases inflammatory diseases and cancer. Also disclosed are pharmaceutical compositions comprising these compounds and processes for preparing these compounds.
Patent NZ-540781-A (NZ)
Title: Vibratory screen with first, second and third screens bonded together with fusible material
Inventor: CARR BRIAN S
IPC: B21F99/00
Filed: 2003-11-13
Abstract: A screen includes three or four layers of woven metal screen cloth. The coarsest of these layers is a structural layer (26) includes threads (32) which are woven into the cloth with surfaces (32) which are fusible below a temperature at which the other layers of screen cloth are heat affected. These woven threads (28) include each of the threads in the coarse screen cloth with the coated threads being wire with fusible polypropylene or polyethylene coatings (30). The cloth could alternatively be coated or a fusible grid (not shown) used. A support layer (12) above the structural layer (26) may include a woven metal screen with woven elements (18) which are either coated with fusible material or are solidly of fusible material woven periodically therethrough in at least one direction. A fusible grid (not shown) could alternatively be employed. Screens are laminated with one or two fine mesh screens (10, 14) heated on the support woven screen cloth (12) with fusible surfaces (22) to locate the fusible material in the finer cloths (10, 14). The structural layer (26) of woven screen cloth has the fusible surfaces (32) only encapsulating the support layer (12) just above and not the finer screen cloths (10, 14) on the other side of the support layer.
Patent NZ-542576-A (NZ)
Title: Submicron oil-in-water emulsions composed of a non-metabolizable oil, at least one surfactant, and an aqueous component, where the oil is dispersed in the aqueous component with al droplet size in the submicron range
Inventor: DOMINOWSKI PAUL JOSEPH
IPC: A61K39/09
Filed: 2004-03-22
Abstract: Disclosed is a submicron oil-in-water emulsion for use as a vaccine adjuvant comprising a light hydrocarbon non-metabolizable oil, a surfactant, and an aqueous component, wherein said oil is dispersed in said aqueous component and the mean oil droplet size of less than 1 ìm is obtained using a microfluidizer.
Patent NZ-549012-A (NZ)
Title: RTV silicone composition offering rapid bond strength
Inventor: WILLIAMS DAVID A
IPC: C08K5/57
Filed: 2005-02-28
Abstract: Disclosed is a curable two part sealant composition comprising a first component (A) and a second component (B), said first component (A) comprising: (a) diorganopolysiloxane in an amount ranging from 5 weight percent to 80 weight percent of the total composition wherein the silicon atom at each polymer chain end is silanol terminated; (b) diorganopolysiloxane in an amount ranging from 5 weight percent to 35 weight percent of the total composition wherein the silicon atom at each polymer chain end is alkyl terminated; said second component (B) comprising: (b) diorganopolysiloxane in an amount ranging from 5 weight percent to 35 weight percent of the total composition wherein the silicon atom at each polymer chain end is alkyl terminated; (c) an alkylsilicate in an amount ranging from 0.1 weight percent to about 10 weight percent of the total composition; (d) a condensation catalyst in an amount ranging from about 0.001 weight percent to 1 weight percent of the total composition; and (e) an alkoxysilane adhesion promoter in an amount ranging from 0.1 weight percent to 20 weight percent of the total composition; wherein the weight ratio of the first component (A) to second component (B) is approximately 13 to 1; and wherein said sealant composition has a green strength of from 6.895 kPa [1 psi] to517.1 kPa [75 psi] as measured by WPSTM test C-1221 after curing for a time period of from 1 minute to 60 minutes.
Patent NZ-549184-A (NZ)
Title: Ink cartridge attachment/detachment device, recording apparatus, liquid ejection apparatus, and liquid container
Inventor: SAKAI YASUTO
IPC: B41J2/175
Filed: 2004-12-21
Abstract: An ink cartridge (611) comprising: a case (612) having a top wall (612b), a bottom wall (612c), a front wall (612a), a rear wall (612f) and first and second sidewalls (612d, 612e). The ink cartridge (611) has one or more ink supply portions (616a) formed in the front wall (612a). There are one or more ink containing portions (613, fig.40) defined within the case (612) and in fluid communication with respective said ink supply portions (616a). The ink cartridge (611) has a first recess (621) recessed from the first sidewall (612d) and a first protrusion (623) projecting from a first plane in which at least part of the first sidewall (612d) lies. Furthermore there is provided a second recess recessed from the second sidewall (612e) and a second protrusion projecting from a second plane in which at least part of the second sidewall (612e) lies. The ink cartridge is also provided with a third recess (619) and a circuit board disposed in the third recess (619); wherein the first protrusion (623) is located adjacent to the first recess (621) and the second protrusion is located adjacent to the second recess; and the circuit board is accessible through an opening of the third recess (619), which is opened at the front wall (612a).
Patent NZ-551370-A (NZ)
Title: Compounds and methods for inhibiting mitotic progression by inhibiting of aurora kinase
Inventor: CLAIBORNE CHRISTOPHER F
IPC: C07D491/14
Filed: 2005-05-12
Abstract: Disclosed are compounds of formula (A) that inhibit aurora kinase. Further disclosed are pharmaceutical compositions comprising the compounds, and the use of the compounds in the manufacture of medicaments for the treatment of cancer.
Patent NZ-552008-A (NZ)
Title: Hypoxic training apparatus
Inventor: CHAPMAN ANDREW MICHAEL
Filed: 2006-07-10
Abstract: A hypoxic training apparatus is provided. The apparatus includes a bellows and a housing for the bellows. The housing is adapted to be configurable between an opened state and a closed state. The housing encloses the bellows when in the closed state. The housing provides a mount for the bellows when in the opened state.
Patent NZ-552605-A (NZ)
Title: Flexible electromagnetic acoustic transducer sensor
Inventor: FLORA JOHN
Filed: 2005-07-20
Abstract: An electromagnetic acoustic transducer is disclosed. The transducer is adapted to conform to the surface of a non-planar test substrate. The transducer is also adapted for generation and detection of ultrasonic acoustic waves and comprises an array of flexible multiple-pole magnets conformable to the non-planar test substrate surface, where the magnets contain magnetic poles and interconnecting segments; and where the magnetic poles are disposed in a plurality of rows. A method of interrogating a test substrate using the transducer is also disclosed.
Patent NZ-554270-A (NZ)
Title: Method and apparatus for delivering at least one chemotheraphy agent to the abdomen
Inventor: SPEARMAN PATRICK R
IPC: A61M37/00
Filed: 2004-10-07
Abstract: An apparatus for introducing at least one agent into the abdomen P of a patient comprising a) an insufflation device 915 to provide pressure and volumetrically controlled gas in a manner suitable for laparoscopic surgery, b) a heater/hydrator 120 connected to the insufflation device 915 downstream thereof, the heater/hydrator 120 having a heater and an absorbent material contained therein, c) at least a first structure 919 comprising at least a first fluid flow path extending at least a portion of the distance between the insufflation device 915 and the heater/hydrator 120, d) at least a second structure 920 comprising at least a second flow path extending at least a portion of the distance between the heater/hydrator 120 and the abdomen P, and e) a chamber 925 adapted to be connected to either the first structure 919 or the second structure 920 and adapted to supply the at least one agent to the interior of the abdomen P through either the first flow path, or the second flow path, or both, wherein the agent is selected from the group consisting of a chemotherapy agent, an antibiotic agent, an anti-adhesion agent and an anaesthetic agent.
Patent NZ-560515-A (NZ)
Title: Corrosion protection system for transport pipe
Inventor: MAMISH ABBOUD
IPC: B32B25/04
Filed: 2006-01-13
Abstract: A method of applying corrosion and mechanical protection to a pipeline, the method comprising providing a substrate having a surface, the substrate comprising at least a portion of the pipeline, applying a hot melt adhesive onto the substrate surface by heating the hot melt adhesive between 300°F (approximately 149°C) to 450°F (approximately 232°C) and spraying the hot melt adhesive through an orifice onto the substrate surface, the hot melt adhesive having a viscosity of equal to or less than about 40,000 cps at 425°F (approximately 218°C), and applying a tape to the hot melt adhesive, the tape having a polymeric backing.
Patent NZ-563572-A (NZ)
Title: Method for producing a core material reinforcement for sandwich structures and said sandwich structures
Inventor: ROTH MATTHIAS ALEXANDER
IPC: B29C70/08
Filed: 2006-04-05
Abstract: A reinforcing method for core composites where a gripper system 2 makes an insertion from one side of the core composite 4 to the other side, grips a reinforcing structure 6 and pulls it back into the core composite 4 with a backward movement. The method is the same when the cover layers 3 5 of the core composite 4 are present.
Patent NZ-571208-A (NZ)
Title: Anti-5T4 antibodies and uses thereof
Inventor: BOGHAERT ERWIN R
IPC: C07K16/00
Filed: 2007-03-09
Abstract: An anti-5T4 antibody that comprises a heavy chain variable region having the amino acid sequence of SEQ ID NO: 2 and a light chain variable region having the amino acid sequence SEQ ID NO: 4. The antibody binds the human 5T4 protein between residues 173-252 and 276-355. The antibody can be used as an antibody/drug conjugate for delivering a drug to 5T4-expressing cells.